Corporate Governance & Risk Management

Strong governance starts with our highest governing body, the Xylem Board of Directors, which is led by our independent Board Chair.

As of the end of 2018, our Board consisted of 10 members, all of whom were independent with the exception of our Chief Executive Officer. On March 27, 2019, our Board elected an additional independent director, bringing the Board to 11 members.

Our Board is elected annually by our shareholders to oversee how Xylem’s employees and management conduct business under the direction of our Chief Executive Officer and to ensure that the interests of the shareholders in the long-term health, success and financial strength of the company are being served. The core responsibility of the Board is to exercise its business judgment to act in what the Board reasonably believes are the best interests of Xylem and its shareholders to build long-term sustainable value. In considering the best interests of Xylem and its shareholders,the Board may also consider the effects on Xylem’s other stakeholders, including its employees,suppliers, customers and communities in which our offices or other facilities are located. The Board recognizes that the long-term interests of shareholders are advanced by responsibly addressing the concerns of these other stakeholders.

The Board, together with the committees it has established to assist in discharging its duties, is guided by our Corporate Governance Principles, articles of incorporation, by-laws, Committee Charters and Code of Conduct.

2018 Reporting

  • Board Meetings: 6
  • Committee meetings: 22
  • Overall attendance: 96 percent

Meet the Members of our Board

Read the 2019 Proxy Statement

Learn more about our earnings and financial information